« Back
Home /
CPI1189

CPI1189

Item no.	TMO-T3561-5mg
Manufacturer	TargetMol
CASRN	183619-38-7
Amount	5 mg
Quantity options	100 mg 10 mM x 1 mL (in DMSO) 10 mg 1 mL 1 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category	Neuroscience Neuroinflammation Metabolism Diabetes Glucose Homeostasis Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Citations	1. Bjugstad KB,et al. Preventive actions of a synthetic antioxidant in a novel animal model of AIDS dementia. Brain Res. 1998 Jun 8;795(1-2):349-57.
Smiles	CC(=O)Nc1ccc(cc1)C(=O)NC(C)(C)C
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	CPI 1189, REN-1189, CPI-1189
Shipping condition	Cool pack
Available
Manufacturer - Targets	TNF
	TNF
Shipping Temperature	cool pack
Storage Conditions	-20°
Molecular Weight	234, 29
Target names or alias	CPI-1189 , REN-1189 , CPI 1189
Description	CPI1189 (REN-1189) is a TNF-a release inhibitor potentially for the treatment of sciatica and postherpetic neuralgia.
Pathways	Apoptosis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T3561-5mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 5 mg

available

Request delivery time